Cited by 1,873Pain Mechanisms and TreatmentsPain Management and TreatmentPain Management and Opioid Use

The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

Open access

Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T.·2010·European Journal of Neurology

DOI 10.1111/j.1468-1331.2010.02999.x

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND AND OBJECTIVES: This second European Federation of Neurological Societies Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005. METHODS: Studies were identified using the Cochrane Database and Medline. Trials were classified according to the aetiological condition. All class I and II randomized controlled trials (RCTs) were assessed; lower class studies were considered only in conditions that had no top-level studies. Treatments administered using repeated or single administrations were considered, provided they are feasible in an outpatient setting. RESULTS: Most large RCTs included patients with diabetic polyneuropathies and post-herpetic neuralgia, while an increasing number of smaller studies explored other conditions. Drugs generally have similar efficacy in various conditions, except in trigeminal neuralgia, chronic radiculopathy and HIV neuropathy, with level A evidence in support of tricyclic antidepressants (TCA), pregabalin, gabapentin, tramadol and opioids (in various conditions), duloxetine, venlafaxine, topical lidocaine and capsaicin patches (in restricted conditions). Combination therapy appears useful for TCA-gabapentin and gabapentin-opioids (level A). CONCLUSIONS: There are still too few large-scale comparative studies. For future trials, we recommend to assess comorbidities, quality of life, symptoms and signs with standardized tools and attempt to better define responder profiles to specific drug treatments.

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2010.02999.x

Cites

236 of 236 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

5 retracted

Anticonvulsant drugs for acute and chronic pain
Wiffen, P. J., Collins, S., McQuay, H. J., Carroll, D., Jadad, A. R., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001133.pub2 · Cited by 409
Retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J. E., & Moore, R. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452 · Cited by 247
Retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J. E., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452.pub2 · Cited by 230
Retracted
Topical lidocaine for the treatment of postherpetic neuralgia
Khaliq, W., Alam, S., & Puri, N. K. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004846.pub2 · Cited by 160
Retracted
Anticonvulsant drugs for acute and chronic pain
Wiffen, P. J., Collins, S., McQuay, H. J., Carroll, D., Jadad, A. R., & Moore, R. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001133.pub3 · Cited by 153
Retracted
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 3,362
Untitled work
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Self-citation
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126

Show all 236 references

Sorted by citations

Items 801–900 of 1,000

Duloxetine use in painful conditions
Marcus, D. A. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.580739 · Cited by 14
Alleviation of pain in painful diabetic neuropathy
Tajti, J., Szok, D., Majláth, Z., Csáti, A., Petrovics-Balog, A., & Vécsei, L. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1184648 · Cited by 14
“[6,35,36] The recent evidence-based recommendations for oral and topical pharmacotherapy of NP were published by the Neuropathic Pain Special Interest Group (NeuPSIG) of the”
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis
Santis, S. D., Borghesi, C., Ricciardi, S., Giovannoni, D., Fulvi, A., Migliorino, M. R., & Marcassa, C. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s108144 · Cited by 14
The pharmacological management of neuropathic pain
Ko, Y., & Kim, Y. H. (2012) · Journal of Korean Medical Association · doi:10.5124/jkma.2012.55.6.582 · Cited by 14
The role of drugs in bone pain
Marras, F. (2016) · Clinical cases in mineral and bone metabolism · doi:10.11138/ccmbm/2016.13.2.093 · Cited by 14
Therapeutic alternatives in painful diabetic neuropathy: a meta-analysis of randomized controlled trials
Vilar-Palomo, S., Castillo-López, J. M., Munuera-Martínez, P. V., Reina‐Bueno, M., & Pabón‐Carrasco, M. (2018) · The Korean journal of pain · doi:10.3344/kjp.2018.31.4.253 · Cited by 14
Pregabalin and injury: A nested case‐control and case‐crossover study
Miyamoto, Y., Iwagami, M., Aso, S., Matsui, H., Doi, K., & Yasunaga, H. (2020) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4976 · Cited by 14
Delta opioid receptors are essential to the antiallodynic action of Β 2 -mimetics in a model of neuropathic pain
Kremer, M., Megat, S., Bohren, Y., Wurtz, X., Nexon, L., Ceredig, R. A., Doridot, S., Massotte, D., Salvat, É., Yalçın, İ., et al. (2020) · Molecular Pain · doi:10.1177/1744806920912931 · Cited by 16
Topical Analgesics
Stanos, S. P. (2020) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2020.02.002 · Cited by 14
An update on the drug treatment of neuropathic pain. Part 1: antidepressants
(2012) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2012.10.0133 · Cited by 14
Efficacy and Safety of Pregabalin for the Treatment of Neuropathic Pain in Patients Undergoing Hemodialysis
Otsuki, T., Higuchi, T., Yamazaki, T., Okawa, E., Okada, K., & Abe, M. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0464-1 · Cited by 14
Topical analgesics for neuropathic pain: an evidence-informed guide for the practicing clinician
Lawson, E. F., Singla, P., Adler, J. A., Argoff, C. E., Bettinger, J. J., Bhaskar, A., Clarke, H. A., Eidelman, A., Hirani, S., Hooten, W. M., et al. (2025) · Pain Medicine · doi:10.1093/pm/pnaf130 · Cited by 16
Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain
Kupfer, M., & Formal, C. S. (2020) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2020.1730109 · Cited by 13
High-frequency spinal cord stimulation produces long-lasting analgesic effects by restoring lysosomal function and autophagic flux in the spinal dorsal horn
Wang, Z., Liu, Y.-D., Wang, S., & Zhao, P. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.317989 · Cited by 13
“Because conventional pharmacological treatments are only moderately efficacious and have problematic side effects (Finnerup et al., 2005; Attal et al., 2010), spinal cord stimulation (SCS) has been considered an indispensable neuromodulatory treatment in these refractory conditions for decades (Papuć and Rejdak, 2013).”
Background
Monotherapy Versus Combination Therapy in the Treatment of Painful Diabetic Neuropathy: A Systematic Review and Meta-analysis
Dantas, J. M., Oliveira, M. D. J., Silva, L. A. O., Batista, S., Dagostin, C. S., & Schachter, D. C. (2023) · Clinical Drug Investigation · doi:10.1007/s40261-023-01318-y · Cited by 14
“The recommended drugs for combination include gabapentinoids with either tricyclic antidepressants (TCAs) or serotonin and noradrenaline reuptake inhibitors (SNRIs) [16, 18].”
BackgroundMethod
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs
Moretti, A., Snichelotto, F., Liguori, S., Paoletta, M., Toro, G., Gimigliano, F., & Iolascon, G. (2024) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x241253656 · Cited by 15
“76 It can be associated with local side effects, such as irritation and red-ness.”
Background
A comprehensive update on cannabidiol, its formulations and drug delivery systems
Banerjee, S., Saharan, V. A., Banerjee, D., Ram, V., Kulhari, H., Pooja, D., & Singh, A. (2024) · Phytochemistry Reviews · doi:10.1007/s11101-024-10001-9 · Cited by 16
“It has also been approved for this purpose in Canada, New Zealand, and Israel (Attal et al. 2010; Tanasescu and Constantinescu 2013).”
Involvement of Neuroactive Steroids in Pain, Depression and Anxiety
Mifflin, K. A., Benson, C. A., Kerr, B. J., Arıcıoğlu, F., Çetin, M., Dursun, S. M., & Baker, G. B. (2015) · Modern trends in psychiatry · doi:10.1159/000435935 · Cited by 13
Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats
Gündüz, Ö., Oltulu, Ç., Guven, R., Buldum, D., & Ulugöl, A. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0761-7 · Cited by 13
Rationale and design of a multicenter randomized clinical trial with memantine and dextromethorphan in ketamine-responder patients
Pickering, G. P., Pereira, B., Morel, V., Tiberghien-Chatelain, F., Martin, E., Marcaillou, F., Picard, P., Delage, N., de Montgazon, G. B., Sorel, M., et al. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.06.004 · Cited by 13
Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults
Farquhar-Smith, P. W., & Thomas (2013) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s50212 · Cited by 13
The Use of Comfort Kits to Optimize Adult Cancer Pain Management
Blackburn, L. M., Abel, S., Green, L., Johnson, K., & Panda, S. (2018) · Pain Management Nursing · doi:10.1016/j.pmn.2018.01.004 · Cited by 13
“Various antidepressants, anticonvulsants, lidocaine patches, and other medications can be used to treat neuropathic pain (Attal et al., 2010).”
Background
Managing Pain in the Older Cancer Patient
Finnerty, D. T., O’Gara, Á., & Buggy, D. J. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0854-7 · Cited by 13
Patients’ perception about opioids and addiction in South Korea
Kim, C. L., Hong, S. J., Lim, Y. H., Jeong, J. H., Moon, H. S., Choi, H., Park, S. K., Kim, J. E., You, H., & Kim, J. H. (2020) · The Korean journal of pain · doi:10.3344/kjp.2020.33.3.234 · Cited by 13
“Guidelines from both the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain and the European Federation of Neurological Societies Task Force recommend opioids as the second-or third-line treatment for neuropathic pain [6,7].”
Effects of dose titration on adherence and treatment duration of pregabalin among patients with neuropathic pain: A MarketScan database study
Yeh, Y., Cappelleri, J. C., Marston, X. L., & Shelbaya, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0242467 · Cited by 13
Topical Fixed-Dose Combinations: A Way of Progress for Pain Management?
Veloso, C., Cardoso, C., & Vitorino, C. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.06.009 · Cited by 13
Acupuncture therapies for postherpetic neuralgia: a protocol for a systematic review and Bayesian network meta-analysis
Bian, Z., Yu, J., Tu, M., Liao, B., Huang, J., Izumoji, G., Sun, R., Xu, Y., Jiang, Y., He, X., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056632 · Cited by 13
Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment
Motwani, L., Asif, N., Patel, A., Vedantam, D., & Poman, D. S. (2022) · Cureus · doi:10.7759/cureus.25905 · Cited by 13
“Though most of these medications show similar efficacy in the treatment of neuropathy, there have to be special considerations for neuropathy in conditions such as HIV-SN, trigeminal neuralgia (TN), and chronic radiculopathy [55].”
Background
Trends in opioid utilization in Hungary, 2006–2020: A nationwide retrospective study with multiple metrics
Engi, Z., Benkő, R., Soós, G., Szok, D., Csenki, M., Csüllög, E., Balog, A., Csupor, D., Viola, R., Doró, P., et al. (2022) · European Journal of Pain · doi:10.1002/ejp.2011 · Cited by 13
“Weak and strong opioids are recommended as second or third- line drugs in different types of primary and secondary chronic pain syndromes, and also in peripheral or central neuropathic pain (Attal et al., 2010; Dowell et al., 2016; Finnerup et al., 2015).”
Background
Long-Term Results of Gamma Knife Radiosurgery for Trigeminal Neuralgia
Sato, D., Hayashi, M., Horiba, A., Horisawa, S., & Kawamata, T. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.12.110 · Cited by 13
Pain in Postsurgical Orthopedic Rehabilitation: A Multicenter Study
Padua, L., Aprile, I. G., Cecchi, F., Lova, R. M., Arezzo, M. F., Pazzaglia, C., & for the Don Carlo Gnocchi Pain-Rehab Group (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01395.x · Cited by 13
Selective thoracic ganglionectomy for the treatment of segmental neuropathic pain
Weigel, R., Capelle, H., Schmelz, M., & Krauss, J. K. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00141.x · Cited by 13
Effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain: an observational analysis
Lazzari, M., Sabato, A. F., Caldarulo, C., Casali, M., Gafforio, P., Marcassa, C., & Leonardis, F. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.866545 · Cited by 13
Acute Neuropathic Pain Assessment in Burn Injured Patients
Taverner, T., & Prince, J. (2016) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/won.0000000000000182 · Cited by 13
Méthode de rééducation sensitive de la douleur
Quintal, I., Noël, L., Gable, C., Delaquaize, F., Bret-Pasian, S., Rossier, P., Annoni, J., Maupas, E., & Spicher, C. J. (2013) · EMC - Kinésithérapie - Médecine physique - Réadaptation · doi:10.1016/s1283-0887(12)59831-2 · Cited by 13
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study
Aitken, E., McColl, G., & Kingsmore, D. B. (2016) · Pain Medicine · doi:10.1093/pm/pnw139 · Cited by 13
Gasserian Ganglion and Retrobulbar Nerve Block in the Treatment of Ophthalmic Postherpetic Neuralgia: A Case Report
Huang, J., Ni, Z., & Finch, P. M. (2016) · Pain Practice · doi:10.1111/papr.12547 · Cited by 13
Development and characterization of a mucoadhesive sublingual formulation for pain control: extemporaneous oxycodone films in personalized therapy
Parodi, B., Russo, E., Baldassari, S., Zuccari, G., Pastorino, S., Yan, M., Neduri, K., & Caviglioli, G. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1281290 · Cited by 13
Immunohistochemical comparison of astrocytic mGluR5 upregulation in infraorbital nerve- versus sciatic nerve-ligated rat
Michot, B., Deumens, R., & Hermans, E. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.05.035 · Cited by 13
Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders
Marmura, M. J., & Kumpinsky, A. (2018) · CNS Drugs · doi:10.1007/s40263-018-0555-z · Cited by 13
Selective spinal nerve block in ilioinguinal, iliohypogastric and genitofemoral neuralgia
Kale, A., Aytuluk, H., Aytuluk, H., Çam, İ., Başol, G., & Sunnetci, B. (2018) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.23990-18.1 · Cited by 13
Risk Factors of Neuropathic Pain after Total Hip Arthroplasty
Maeda, K., Sonohata, M., Kitajima, M., Kawano, S., & Mawatari, M. (2018) · Hip & Pelvis · doi:10.5371/hp.2018.30.4.226 · Cited by 13
Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
Tofthagen, C., Gonzalez, L., Visovsky, C. M., & Akers, A. (2013) · Chemotherapy Research and Practice · doi:10.1155/2013/547932 · Cited by 13
Low Back Pain Pathogenesis and Treatment
Sakai, Y. (2012) · InTech eBooks · doi:10.5772/2681 · Cited by 14
Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients
Bursi, R., Piana, C., Grevel, J., Huntjens, D. R. H., & Boesl, I. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0400-7 · Cited by 13
The Association between Patient Characteristics and Opioid Treatment Response in Neuropathic and Nociceptive Pain due to Cancer
Haumann, J., van Kuijk, S. M. J., Joosten, E. A. J., & Everdingen, M. H. J. V. D. B.-V. (2018) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0281 · Cited by 13
κ‐ opioid receptors are not necessary for the antidepressant treatment of neuropathic pain
Megat, S., Bohren, Y., Doridot, S., Gavériaux‐Ruff, C., Kieffer, B. L., Freund‐Mercier, M. J., Yalçın, İ., & Barrot, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12963 · Cited by 12
Different Drugs for the Treatment of Painful Diabetic Peripheral Neuropathy: A Meta-Analysis
Lian, J., Ma, L., & Fu, J. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.682244 · Cited by 12
Incidence of complications of herpes zoster in individuals on immunosuppressive therapy: A register-based population study
Chawki, S., Vilcu, A., Etienne, C., Finet, F., Blanchon, T., Souty, C., & Hanslik, T. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.01.003 · Cited by 12
The Roles of Imaging Biomarkers in the Management of Chronic Neuropathic Pain
Pricope, C. V., Tamba, B.-I., Stanciu, G. D., Cuciureanu, M. D., Neagu, A.-N., Creangă-Murariu, I., Dobrovăț, B. I., Urîtu, C. M., Filipiuc, S. I., Pricope, B.-M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113038 · Cited by 12
Gabapentinoid Prescribing Practices at a Large Academic Medical Center
Huang, L. L., Wright, J. A., Fischer, K. M., Croghan, I. T., Nanda, S., Schroeder, D. R., & Vincent, A. (2023) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2022.12.002 · Cited by 12
“Table 3 summarizes the level of evidence supporting (or not supporting) the indications for gabapentinoid prescriptions in the overall cohort.(14-54) Gabapentinoid prescriptions for pain-related indications, such as neuropathic pain, headaches, and musculoskeletal pain, were the most common (82.”
Background
Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
Prnjavorac, B., Kunić, S., Pejanović-Škobić, N., Gorana, N. P., Zirojevic, D., Vukas, S. K., TiricCampara, M., & Skopljak, A. (2023) · Materia Socio Medica · doi:10.5455/msm.2023.35.42-47 · Cited by 12
“In addition to its effect on pain, pregabalin also has a positive effect on the state of depression and anxiety that often occurs in patients with chronic pain, thus improving their quality of life (12).”
Background
Mirogabalin as a novel calcium channel α2δ ligand for the treatment of neuropathic pain: a review of clinical update
Yang, F., Wang, Y., Zhang, M., & Yu, S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1491570 · Cited by 12
“…(NeuPSIG) recommended tricyclic antidepressants (TCAs), serotonin norepinephrine reuptake inhibitors (SNRIs), and gabapentinoids including gamma-aminobutyric acid (GABA) analogs as the ﬁ rst line of treatment for various NP conditions (Attal et al., 2010; Dworkin et al., 2013; Moulin et al., 2014).”
Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients – subgroup analyses from three European clinical trials
Sabatowski, R., Boesl, I., König, S., Buchheister, B., Meier, T., & Baron, R. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1277990 · Cited by 12
Self-citation
Interventions for Refractory Trigeminal Neuralgia: A Bayesian Mixed Treatment Comparison Network Meta-Analysis of Randomized Controlled Clinical Trials
Sridharan, K., & Sivaramakrishnan, G. (2017) · Clinical Drug Investigation · doi:10.1007/s40261-017-0553-9 · Cited by 13
Recommendations for Pharmacologic Therapy of Neuropathic Pain
Haroutounian, S., & Finnerup, N. B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40196-8.00050-4 · Cited by 12
Treatments that are perceived to be helpful for non-neuropathic pain after traumatic spinal cord injury: a multicenter cross-sectional survey
Tsai, C., Bryce, T. N., Delgado, A. D., Mulroy, S. J., MacIntyre, B., Charlifue, S. W., & Felix, E. R. (2021) · Spinal Cord · doi:10.1038/s41393-021-00621-9 · Cited by 12
Considerations for single- versus multiple-drug pharmacotherapy in the management of painful diabetic neuropathy
Pafili, K., & Παπάνας, Ν. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1909570 · Cited by 12
Dermal delivery of amitriptyline for topical analgesia
Kung, C.-P., Sil, B. C., Zhang, Y., Hadgraft, J., Lane, M. E., Patel, B., & McCulloch, R. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00982-x · Cited by 12
Comparing Prodrugs with Acyclovir for Treating Postherpetic Neuralgia among Herpes Zoster Patients: A Systematic Review and Meta-Analysis
Yeh, C., Chang, K.-S., Huang, S., Tsay, S., Tsai, J., & Wang, Y. (2022) · Healthcare · doi:10.3390/healthcare10071181 · Cited by 12
Pregabalin Beneficial Effects on Sleep Quality or Health-Related Quality of Life Are Poorly Correlated With Reduction on Pain Intensity After an 8-Week Treatment Course
Perez‐Lloret, S., Rojas, G. M., Menoni, M. C., Ruiz, G., Velásquez, C., Rodriguez, H., Rey, M. V., & Cardinali, D. P. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31823df2dc · Cited by 12
Effects of β2 agonists on post‐thoracotomy pain incidence
Salvat, É., Schweitzer, B., Massard, G., Meyer, N., Frederic de, B. L. A. Y., Muller, A., & Barrot, M. (2015) · European Journal of Pain · doi:10.1002/ejp.673 · Cited by 12
“…of antidepressant drugs (Yalcin et al., 2009a; Yalcin et al., 2009b) that are a first-line treatment of neuropathic pain (Dworkin et al., 2007; Attal et al., 2010), and that a chronic treatment with b2-agonists may have the same antiallodynic effect as antidepressant drugs (Choucair-Jaafar et…”
Background
Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury
Khan, J., Alghamdi, H., Anwer, M. M., Eliav, E., & Ziccardi, V. B. (2016) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2016.01.022 · Cited by 12
Amitriptyline Therapy in Chronic Pain
Su, M. (2015) · International Archives of Clinical Pharmacology · doi:10.23937/2572-3987.1510001 · Cited by 12
“The major methods of neuropathic pain management include: antidepressants, anticonvulsants, opioids, and adjuvant analgesics [46,47].”
Method
Effect of Patient Education on Reducing Medication in Spinal Cord Injury Patients With Neuropathic Pain
Shin, J. C., Kim, N. Y., Chang, S. H., Lee, J. J., & Park, H.-K. (2017) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2017.41.4.621 · Cited by 12
“Furthermore, neuropathic pain is associated with polypharmacy [10,13-15], and the increased use of medications can lead to increased costs, more side effects, and an increased risk of fatigue as well as confused states, falls, and injuries [11].”
Background
Sparstolonin B selectively suppresses toll‑like receptor‑2 and ‑4 to alleviate neuropathic pain
Jin, G., Jin, X. Y., & Zhou, S. Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7951 · Cited by 12
“Based on the location of lesions, NP is classified into the following two types: Peripheral NP, triggered by damage to the peripheral nervous system; and central NP, triggered by spinal cord injury, stroke or multiple sclerosis (3,4).”
BackgroundInfluential
Papel de las vitaminas B, tiamina, piridoxina y cianocobalamina en el dolor de espalda y otras condiciones musculoesqueléticas: revisión narrativa
Nava-Mesa, M. O., & Lanche, G. R. A. (2021) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2021.01.010 · Cited by 12
Cannabinoids for the treatment of refractory neuropathic pruritus in amyotrophic lateral sclerosis: A case report
Lou, K. K. W., Murphy, S., & Talbot, C. (2021) · Palliative Medicine · doi:10.1177/02692163211045314 · Cited by 12
Clinical Characteristics, Patient-Reported Outcomes, and Previous Therapeutic Management of Patients with Uncontrolled Neuropathic Pain Referred to Pain Clinics
Andrés, J. A. D., de la Calle, J. L., Pérez, M., & López, V. (2014) · Pain Research and Treatment · doi:10.1155/2014/518716 · Cited by 12
Postbariatric Surgery Neuropathic Pain (PBSNP): Case Report, Literature Review, and Treatment Options
Kailasam, V. K., DeCastro, C., Macaluso, C., & Kleiman, A. (2014) · Pain Medicine · doi:10.1111/pme.12590 · Cited by 12
Effect of 5% Lidocaine Medicated Plaster on Pain Intensity and Paroxysms in Classical Trigeminal Neuralgia
Tamburin, S., Schweiger, V., Magrinelli, F., Brugnoli, M. P., Zanette, G., & Polati, E. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014544166 · Cited by 12
Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study
Ohishi, A., Chisaki, Y., Hira, D., Nagasawa, K., & Terada, T. (2015) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-015-0032-5 · Cited by 12
“Anti-convulsants, gabapentin and pregabalin are recommended for the first-line therapy in the guidelines for neuropathic pain, and are widely used as adjuvant analgesics for the patients with neuropathic pain, painful diabetic neuropathy, and chemotherapy-induced peripheral neuropathy [5–7].”
Medical Judgments Across the Range of Reported Pain Severity: Clinician and Lay Perspectives
Tait, R. C., Chibnall, J. T., House, K., & Biehl, J. (2015) · Pain Medicine · doi:10.1093/pm/pnv076 · Cited by 12
Oral Chinese herbal medicine for post-herpetic neuralgia: A systematic review and meta-analysis of randomized controlled trials
Liang, H., Coyle, M., Wang, K., Zhang, A. L., Guo, X., Li, H., Xue, C. C., & Lu, C. (2017) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2017.01.005 · Cited by 12
Hypoalgesic effect of Spirulina platensis on the sciatic neuropathic pain induced by chronic constriction injury in male rats
Safakhah, H. A., Tamimi, F., Kor, N. M., Bandegi, A. R., & Ghanbari, A. (2018) · Biomedical Research and Therapy · doi:10.15419/bmrat.v5i9.477 · Cited by 14
Utilisation of medications among elderly patients in intensive care units: a cross-sectional study using a nationwide claims database
Jung, S., & Lee, H. J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026605 · Cited by 12
Persistent pain after dental implant placement
Delcanho, R. E., & Moncada, E. V. (2014) · The Journal of the American Dental Association · doi:10.14219/jada.2014.210 · Cited by 12
Mirtazapine in Veterinary Medicine a Pharmacological Rationale for its Application in Chronic Pain
Saleh (2012) · American Journal of Animal and Veterinary Sciences · doi:10.3844/ajavsp.2012.42.47 · Cited by 11
Models for depression in drug screening and preclinical studies: Future directions
Borsini, F. (2012) · World Journal of Pharmacology · doi:10.5497/wjp.v1.i1.21 · Cited by 11
A data science approach to drug safety: Semantic and visual mining of adverse drug events from clinical trials of pain treatments
Lamy, J.-B. (2021) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2021.102074 · Cited by 13
Empfehlungen der aktualisierten Leitlinie LONTS: Langzeitanwendung von Opioiden bei chronischen nicht-tumorbedingten Schmerzen
Häuser, W., Bock, F., Engeser, P., Hege-Scheuing, G., Hüppe, M., Lindena, G., Maier, C., Norda, H., Radbruch, L., Sabatowski, R., et al. (2015) · Der Schmerz · Cited by 11
Gabapentin, Concomitant Prescription of Opioids, and Benzodiazepines among Kidney Transplant Recipients
Chen, Y., Ahn, J. B., Bae, S., Joseph, C., Schnitzler, M. A., Hess, G. P., Lentine, K. L., Lonze, B. E., Segev, D. L., & McAdams‐DeMarco, M. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000019 · Cited by 11
The effect of intrathecal gabapentin on neuropathic pain is independent of the integrity of the dorsolateral funiculus in rats
Dias, Q. M., Silveira, J. W. S., Reis, G. M., Costa, K. A., Rossaneis, A. C., Fais, R. S., & Prado, W. A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.08.032 · Cited by 11
Association between wind-up ratio and central serotonergic function in healthy subjects and depressed patients
Uhl, I., Krumova, E. K., Regeniter, S., Bär, K., Norra, C., Richter, H., Assion, H., Westermann, A., Juckel, G., & Maier, C. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.033 · Cited by 11
Management of patients with back pain in outpatient practice
Gerasimova, O. N., Parfenov, V. A., Gerasimova, O. N., & Parfenov, V. A. (2010) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2010-120 · Cited by 11
Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions
Ogawa, S., Arakawa, A., Hayakawa, K., & Yoshiyama, T. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0423-x · Cited by 12
Factors associated with changes in exposure to anticholinergic and sedative medications in elderly hospitalized patients: multicentre longitudinal study
Dauphinot, V., Faure, R., Bourguignon, L., Goutelle, S., Krolak‐Salmon, P., & Mouchoux, C. (2016) · European Journal of Neurology · doi:10.1111/ene.13228 · Cited by 11
“The management of neuropathic pain after a stroke might also explain the increase in exposure to anticholinergic and sedative drugs [22].”
Background
Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data Center
Honda, M., Murata, T., Ebata, N., Fujii, K., & Ogawa, S. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13784 · Cited by 11
Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model
Stepanović-Petrović, R. M., Micov, A. M., Tomic´, M. A., & Pecikoza, U. B. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4583-z · Cited by 11
Axonal Sensorimotor Polyneuropathies
Li, Y. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000514 · Cited by 11
A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy
Battaglini, E., Park, S. B., Barnes, E. H., & Goldstein, D. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.04.011 · Cited by 11
Possible involvement of the peripheral Mu-opioid system in antinociception induced by bergamot essential oil to allodynia after peripheral nerve injury
Komatsu, T., Katsuyama, S., Uezono, Y., Sakurada, C., Tsuzuki, M., Hamamura, K., Bagetta, G., Sakurada, S., & Sakurada, T. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.053 · Cited by 11
Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnts (PDN-SCOPE): protocol for a multicentre cross-sectional registry study of clinical characteristics and treatment in China
Zhang, Y., Li, N., Zhao, Y., & Fan, D. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025722 · Cited by 11
Autologous fat grafting seems to alleviate postherpetic neuralgia – a feasibility study investigating patient-reported levels of pain
Sollie, M., Thomsen, J. B., & Sørensen, J. A. (2020) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2020.08.038 · Cited by 11
Green HPLC–DAD and HPTLC Methods for Quantitative Determination of Binary Mixture of Pregabalin and Amitriptyline Used for Neuropathic Pain Management
Naguib, I. A., Ali, N. A., Elroby, F. A., & Elghobashy, M. R. (2021) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmab031 · Cited by 11
Thymus persicus (Ronniger ex Rech. f.) Jalas alleviates nociceptive and neuropathic pain behavior in mice: Multiple mechanisms of action
Abed, D. Z., Sadeghian, R., Mohammadi, S., & Akram, M. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114695 · Cited by 11
Pharmacologic Management of Neuropathic Pain
Nudell, Y., Dym, H., Sun, F., Benichou, M., Malakan, J., & Halpern, L. R. (2021) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2021.09.002 · Cited by 11
Spinal Cord Injury
Bryce, T. N., Huang, V. S., & Escalon, M. X. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-62539-5.00049-7 · Cited by 15
Outcome Measures in Randomized-controlled Trials of Neuropathic Pain Conditions
Mehta, P., Claydon, L. S., Hendrick, P. A., Winser, S. J., & Baxter, D. G. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000088 · Cited by 11
Prevalencia del dolor neuropático (DN), según DN4, en atención primaria
Blanco, E., Gálvez, R., Zamorano, E., López, V., & Pérez, M. (2011) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2011.10.012 · Cited by 11

Authors: Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T.
Affiliations: Inserm (FR)
Sapienza University of Rome (IT)
University Hospital Schleswig-Holstein (DE)
Helsinki University Hospital (FI)
Karolinska University Hospital (SE)
Aarhus University Hospital (DK)
University of Liverpool (GB)
Corresponding author: Attal, N.
ORCID: Attal, N.
Cruccu, G.
Baron, R.
Haanpää, M.
Hansson, P.
Jensen, T. S.
Nurmikko, T.
Venue: European Journal of Neurology
Publisher: Wiley
Published: 2010-04-07
Volume: 17
Issue: 9
Pages: 1113
ISSN: 1351-5101 (ISSN-L)
1468-1331
DOI: 10.1111/j.1468-1331.2010.02999.x
OpenAlex: W2128412489
Cited by: 1,873
References: 236
Citations by year: 2026: 39 · 2025: 59 · 2024: 85 · 2023: 81 · 2022: 91 · 2021: 128 · 2020: 134 · 2019: 112 · 2018: 102 · 2017: 151 · 2016: 136 · 2015: 152 · 2014: 185 · 2013: 185 · 2012: 121
FWCI: 89.44
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: European Journal of Neurology (publishedVersion)
PubMed (publishedVersion)
IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics: Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords: neuropathic pain, pharmacotherapy, diabetic polyneuropathy, postherpetic neuralgia, trigeminal neuralgia, chronic radiculopathy, HIV neuropathy, tricyclic antidepressants, pregabalin, gabapentin, tramadol, opioids, duloxetine, venlafaxine, topical lidocaine, capsaicin patch, combination therapy, treatment efficacy
MeSH terms: Gabapentin, Amines, Analgesia, Analgesics, Analgesics, Opioid, Antidepressive Agents, Tricyclic, Cyclohexanecarboxylic Acids, Drug Therapy, Combination, Europe, gamma-Aminobutyric Acid, Humans, Neuralgia, Peripheral Nervous System Diseases, Randomized Controlled Trials as Topic, Treatment Outcome, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks